Jeffrey Davidson joins Karmanos Cancer Institute Board of Directors

    NEXT STORY
    Flexion Therapeutics Presents Updated Results from Clinical Trial Evaluating Repeat Administration of ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) at Osteoarthritis Research Society International World Congress
    PREV STORY
    Shire plc : 1st Quarter Results
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adverum Biotechnologies Presents Long-term Data through March 10, 2021 from the OPTIC Trial of ADVM-022 Intravitreal Gene Therapy in Treatment-experienced Wet AMD Patients at ARVO 2021

    author_avatar
    NASDAQ Market News

    Cempra Announces Presentations at Upcoming Investor Conferences and Provides Merger Process Update

    CHAPEL HILL, N.C., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Achaogen Highlights Multiple Plazomicin Presentations at IDWeek 2018

    SOUTH SAN FRANCISCO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), ...

    author_avatar
    NASDAQ Market News